Sign in
4

Changes in Ownership

Niagen Bioscience, Inc. Filed Acc 0001415889-16-007038

CEO, PRESIDENT bought 1,500 shares at $3.32 ($4,980)

From the SEC's structured data for this filing

Trades in this filing

Jaksch Frank L Jr · CEO, PRESIDENT

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2016-09-01 Purchase : show line 1 in the form +1,500 $3.32 $4,980 199,557 D
Open-market purchases · 1,500 sh · avg $3.32 · $4,980
Loading xslF345X03/form4-09022016_010924.xml…